TRESSA ESTY: Open Payments
NPI 1720282718 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 42 payments from 14 companies in 2025. Trend: 2023 $1,208 · 2024 $1,098 · 2025 $1,086
Food & beverage: $1,076Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $221 |
| Novartis Pharmaceuticals Corporation | 7 | $202 |
| Lilly USA, LLC | 6 | $183 |
| REVANCE THERAPEUTICS, INC. | 2 | $131 |
| Incyte Corporation | 3 | $80 |
| Janssen Biotech, Inc. | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
Products named: TALTZ, COSENTYX, SKYRIZI, DAXXIFY, OPZELURA, RINVOQ, TREMFYA, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
